April COVID-19 Vaccine Event (Tentative)

• New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA booster after completion of a monovalent primary series; it replaces all prior booster recommendations for this age group

• Recommendations for use of a bivalent Moderna booster dose in people ages 18 years and older
• Recommendations for use of a bivalent Pfizer-BioNTech booster dose in people ages 12 years and older

• Updated guidance for observation periods following COVID-19 vaccination
• Updated guidance on COVID-19 vaccination and multisystem inflammatory syndrome (MIS) in children (MIS-C) and in adults (MIS-A)

See if you are eligible to get a COVID-19 vaccine: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html